Your browser doesn't support javascript.
loading
Germany's journey toward 14 Tesla human magnetic resonance.
Ladd, Mark E; Quick, Harald H; Speck, Oliver; Bock, Michael; Doerfler, Arnd; Forsting, Michael; Hennig, Jürgen; Ittermann, Bernd; Möller, Harald E; Nagel, Armin M; Niendorf, Thoralf; Remy, Stefan; Schaeffter, Tobias; Scheffler, Klaus; Schlemmer, Heinz-Peter; Schmitter, Sebastian; Schreiber, Laura; Shah, N Jon; Stöcker, Tony; Uder, Michael; Villringer, Arno; Weiskopf, Nikolaus; Zaiss, Moritz; Zaitsev, Maxim.
  • Ladd ME; Medical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. mark.ladd@dkfz.de.
  • Quick HH; Faculty of Medicine, Heidelberg University, Heidelberg, Germany. mark.ladd@dkfz.de.
  • Speck O; Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, Germany. mark.ladd@dkfz.de.
  • Bock M; Erwin L. Hahn Institute for MRI, University of Duisburg-Essen, Essen, Germany. mark.ladd@dkfz.de.
  • Doerfler A; Erwin L. Hahn Institute for MRI, University of Duisburg-Essen, Essen, Germany.
  • Forsting M; High-Field and Hybrid MR Imaging, University Hospital Essen, Essen, Germany.
  • Hennig J; Department of Biomedical Magnetic Resonance, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Ittermann B; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Möller HE; Center for Behavioural Brain Sciences, Magdeburg, Germany.
  • Nagel AM; Leibniz Institute for Neurobiology (LIN), Magdeburg, Germany.
  • Niendorf T; Division of Medical Physics, Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Remy S; Department of Neuroradiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Schaeffter T; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.
  • Scheffler K; Division of Medical Physics, Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Schlemmer HP; Medical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.
  • Schmitter S; Methods and Development Group Nuclear Magnetic Resonance, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
  • Schreiber L; Medical Physics in Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Shah NJ; Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Stöcker T; Berlin Ultrahigh Field Facility (B.U.F.F.), Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Uder M; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Villringer A; Leibniz Institute for Neurobiology (LIN), Magdeburg, Germany.
  • Weiskopf N; Medical Physics and Metrological Information Technology, Physikalisch-Technische Bundesanstalt (PTB), Berlin, Germany.
  • Zaiss M; Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
  • Zaitsev M; Department of Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.
MAGMA ; 36(2): 191-210, 2023 Apr.
Article en En | MEDLINE | ID: mdl-37029886
ABSTRACT
Multiple sites within Germany operate human MRI systems with magnetic fields either at 7 Tesla or 9.4 Tesla. In 2013, these sites formed a network to facilitate and harmonize the research being conducted at the different sites and make this technology available to a larger community of researchers and clinicians not only within Germany, but also worldwide. The German Ultrahigh Field Imaging (GUFI) network has defined a strategic goal to establish a 14 Tesla whole-body human MRI system as a national research resource in Germany as the next progression in magnetic field strength. This paper summarizes the history of this initiative, the current status, the motivation for pursuing MR imaging and spectroscopy at such a high magnetic field strength, and the technical and funding challenges involved. It focuses on the scientific and science policy process from the perspective in Germany, and is not intended to be a comprehensive systematic review of the benefits and technical challenges of higher field strengths.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Imagen de Cuerpo Entero Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Imagen por Resonancia Magnética / Imagen de Cuerpo Entero Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article